PME-1 suppresses anoikis, and is associated with therapy relapse of PTEN-deficient prostate cancers
Aakula, A.; Isomursu, A.; Rupp, C.; Erickson, A.; Kauko, O.; Shah, P.; Padzik, A.; Pokharel, Y. R.; Kaur, A.; Li, S.-P.; Trottman, L.; Taimen, P.; Rannikko, A.; Lammerding, J.; Paatero, I.; Mirtti, T.; Ivaska, J.; Westermarck, J.
Show abstract
While organ-confined PCa is mostly therapeutically manageable, metastatic progression of PCa remains an unmet clinical challenge. Resistance to anoikis, a form of cell death initiated by cell detachment from the surrounding extracellular matrix, is one of the cellular processes critical for PCa progression towards aggressive disease. Therefore, further understanding of anoikis regulation in PCa might provide therapeutic opportunities. Here, we discover that PCa tumors with concomitantly compromised function of two tumor suppressor phosphatases, PP2A and PTEN, are particularly aggressive, having less than 50% 5-year secondary-therapy free patient survival. Functionally, overexpression of PME-1, a PP2A inhibitor protein, inhibits anoikis in PTEN-deficient PCa cells. In vivo, PME-1 inhibition increased apoptosis in in ovo PCa tumor xenografts, and attenuated PCa cell survival in zebrafish circulation. Molecularly, PME-1 deficient PCa cells display increased trimethylation at lysines 9 and 27 of histone H3 (H3K9me3 and H3K27me3), a phenotype corresponding to increased apoptosis sensitivity. In summary, we discover that PME-1 overexpression supports anoikis resistance in PTEN-deficient PCa cells. Clinically, the results identify PME-1 as a candidate biomarker for a subset of particularly aggressive PTEN-deficient PCa.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Disassembly of hemidesmosomes promotes tumorigenesis in PTEN-negative prostate cancer by targeting plectin into focal adhesions 96%
- ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis 95%
- Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition 95%
Similar papers in this journal
- HSP90α and KLK6 Co-Regulate Stress-Induced Prostate Cancer Cell Motility 93%
- Systemic ablation of Camkk2 impairs metastatic colonization and improves insulin sensitivity in TRAMP mice: Evidence for cancer cell-extrinsic CAMKK2 functions in prostate cancer 92%
- Down-regulation of AKT proteins slows the growth of mutant-KRAS pancreatic tumors 92%
Similar papers in this journal
- RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer 93%
- Tumor-infiltrating nerves create an electro-physiologically active microenvironment and contribute to treatment resistance 93%
- The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage. 92%
Similar papers in this journal
- DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis 93%
- Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis 93%
- The CIC-ERF co-deletion underlies fusion independent activation of ETS family member, ETV1, to drive prostate cancer progression 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.